If you read the Journal report reproduced above, it answers your question. HERR-Vaxx is the product.
Go to IMU website and you will find the results from Phase 1. IMU are about to commence Phase 2.
Results of Phase 1 include 1 patient complete recovery, and others with significant tumour reduction. Small cohort, but amazing results.
There is no reason that the results from Phase 2 will not be equally as impressive. If that happens, a giant step forward for some cancer sufferers, and shareholders as well.
A forecast timeline was published in the April Newsletter 2020, and in the Emergence Presentation February 2020. Most of the information you seek is summarised in those documents.
Enjoy the reading.
Ann: New mimotope cancer vaccine results published, page-19
-
- There are more pages in this discussion • 41 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $356.9M | |||
| Open | High | Low | Value | Volume |
| 4.9¢ | 4.9¢ | 4.8¢ | $328.5K | 6.792M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 45 | 5443565 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 2171910 | 5 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |